YATHARTHNSE5 August 2025

Yatharth Hospital & Trauma Care Services Limited has informed the Exchange about Investor Presentation

Yatharth Hospital & Trauma Care Services Limited

YH/SE/31/2025-26 August 05, 2025

The Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1 G Block, Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051 Symbol: YATHARTH ISIN: INE0JO301016

Dept. of Listing Operations BSE Limited, P J Towers, Dalal Street, Mumbai -400001, India

Scrip Code: 543950 ISIN: INE0JO301016

Sub:-Investor's presentation- Q1 &FY26 Results.

Please find enclosed Investor's Presentation for Q1 & FY26 Results pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015.

Kindly take the same in your records.

Thanking you, For Yatharth Hospital and Trauma Care Services Limited

Dr Ajay Kumar Tyagi Chairman and Whole-time Director DIN: 01792886

Encl.: As above

Q1 FY26 Earnings Presentation August 5, 2025

Disclaimer

Certain matters discussed in this Presentation may contain statements regarding the company’s market opportunity and business

prospects that are individually and collectively forward-looking statements. Such forward-looking statements doesn’t guarantee

future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These

risks and uncertainties include, but are not limited to, the performance of the economy, industry, competition, the company’s

ability to successfully implement its strategy, technological implementation, changes and advancements, the company’s market

preferences and its exposure to market risks, as well as other risks. The company’s actual results, levels of activity, performance or

achievements could differ materially and adversely from results expressed in or implied by this presentation. The company

assumes no obligation to update any forward-looking information contained in this presentation. Any forward-looking statements

and projections made by third parties included in this presentation are not adopted by the company and the company is not

responsible for such third-party statements and projections. You are cautioned not to place undue reliance on these forward-

looking statements, which are based on the current view of the management of the Company on future events.

Q1 FY26 Performance Highlights

Q1 FY26 Performance Summary

Bed Capacity*

2,300+ beds

Revenue

Rs. 2,578 mn +22% YoY

PAT

Rs. 425 mn +40% YoY

Occupancy

65% +4% YoY

EBITDA

Rs. 645 mn +20% YoY

PAT Margin

16.5% +214bps YoY

ARPOB

Rs. 32,395 +6% YoY

EBITDA Margin

25.0% -32bps YoY

ALOS

4.10

*1,605 beds operating in Q1 FY26, excluding hospital in Delhi & Faridabad

Robust Improvement in Financial Parameters

Revenue (Rs mn)

EBITDA (Rs mn) & EBITDA%

+22% YoY

+11% QoQ

2,118

2,178

2,192

2,318

2,578

Q1FY25

Q2FY25

Q3FY25

Q4FY25

Q1FY26

PBT (Rs mn) & PBT%

20.3%

18.4%

18.3%

20.9%

22.9%

430

401

402

485

591

27%

26%

25%

24%

23%

22%

21%

20%

19%

18%

17%

16%

15%

14%

13%

12%

11%

10%

80 0 795 790 785 780 775 770 765 760 755 750 745 740 735 730 725 720 715 710 705 700 69 5 69 0 68 5 68 0 675 670 66 5 66 0 65 5 65 0 64 5 64 0 635 630 625 620 615 610 60 5 60 0 59 5 59 0 58 5 58 0 575 570 56 5 56 0 55 5 55 0 54 5 54 0 535 530 525 520 515 510 50 5 50 0 49 5 49 0 48 5 48 0 475 470 46 5 46 0 45 5 45 0 44 5 44 0 435 430 425 420 415 410 40 5 40 0 395 390 385 380 375 370 365 360 355 350 345 340 335 330 325 320 315 310 305 300 295 290 285 280 275 270 265 260 255 250 245 240 235 230 225 220 215 210 205 200 195 190 185 180 175 170 165 160 155 150 145 140 135 130 125 120 115 110 105 100 95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0

1000 99 5 99 0 98 5 98 0 975 970 96 5 96 0 95 5 95 0 94 5 94 0 935 930 925 920 915 910 90 5 90 0 89 5 89 0 88 5 88 0 875 870 86 5 86 0 85 5 85 0 84 5 84 0 835 830 825 820 815 810 80 5 80 0 795 790 785 780 775 770 765 760 755 750 745 740 735 730 725 720 715 710 705 700 69 5 69 0 68 5 68 0 675 670 66 5 66 0 65 5 65 0 64 5 64 0 635 630 625 620 615 610 60 5 60 0 59 5 59 0 58 5 58 0 575 570 56 5 56 0 55 5 55 0 54 5 54 0 535 530 525 520 515 510 50 5 50 0 49 5 49 0 48 5 48 0 475 470 46 5 46 0 45 5 45 0 44 5 44 0 435 430 425 420 415 410 40 5 40 0 395 390 385 380 375 370 365 360 355 350 345 340 335 330 325 320 315 310 305 300 295 290 285 280 275 270 265 260 255 250 245 240 235 230 225 220 215 210 205 200 195 190 185 180 175 170 165 160 155 150 145 140 135 130 125 120 115 110 105 100 95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0

25.3%

25.1%

24.6%

25.0%

537

546

549

570

645

Q1FY25

Q2FY25

Q3FY25

Q4FY25

Q1FY26

PAT (Rs mn) & PAT%

14.3%

14.2%

13.9%

16.7%

16.5%

304

310

305

387

425

Q1FY25

Q2FY25

Q3FY25

Q4FY25

Q1FY26

Q1FY25

Q2FY25

Q3FY25

Q4FY25

Q1FY26

27%

26%

25%

24%

23%

22%

21%

20%

19%

18%

17%

16%

15%

14%

13%

12%

11%

10%

27%

26%

25%

24%

23%

22%

21%

20%

19%

18%

17%

16%

15%

14%

13%

12%

11%

10%

Healthy Performances across Operational Metrics

IPD & OPD Volumes (in ‘000s)

Occupancy (%)

IPD Volume

OPD Volume

102

116

109

120

103

124

105

65%

61%

60%

Q1FY25

Q2FY25

Q3FY25

Q4FY25

Q1FY26

Q1FY25

Q2FY25

Q3FY25

Q4FY25

Q1FY26

IPD & OPD Revenue (Rs mn)

IPD Revenue

OPD Revenue

2,178

270

1,908

2,192

249

1,943

2,318

254

2,064

2,578

290

2,288

250 0

230 0

210 0

190 0

170 0

150 0

350 0

300 0

250 0

200 0

150 0

100 0

500

2,118

236

1,882

ARPOB (Rs.)

32,395

31,441

30,551

30,641

30,652

Q1FY25

Q2FY25

Q3FY25

Q4FY25

Q1FY26

Q1FY25

Q2FY25

Q3FY25

Q4FY25

Q1FY26

ARPOB – Average Revenue Per Occupied Bed

Diversifying Revenues across Hospitals

Greater Faridabad,

Rs. 15 mn

Noida Extension

38%

Rs. 802 mn

Jhansi- Orchha

Rs. 112 mn

Q1 FY25 Rs. 2,118 mn

Noida, 23%

Rs. 481 mn

Noida Extension

34%

Rs. 862 mn

Q1 FY26 Rs. 2,578 mn

Greater Faridabad, 9% Rs. 234 mn

Jhansi- Orchha 7%

Rs. 182 mn

Greater Noida

33%

Rs. 709 mn

Noida, 20% Rs. 525 mn

Greater Noida

30%

Rs. 776 mn

• New Hospitals led the growth momentum, with Jhansi-Orchha hospital recording robust growth of 63% YoY

• Within a year of operations, Greater Faridabad hospital has grown to contribute 9% to the group's revenue in Q1 FY26

Q1 FY26 Consolidated Revenue is after adjustment of inter-company transactions of Rs 2 mn

Expanding High Value Specialities across Hospitals

Diverse mix of specialities at all hospitals

Noida extension hospital registered highest share of super specialities

18%

12%

11%

10%

6% 4%3% 5%

General Surgery 4%

Pediatrics 2%

Q1 FY2026

Q1 FY2025

23%

11%

FY2021

56%

Internal Medicine

Nephrology & Urology

Cardiology

Pulmonology

Gastroenterology

Pediatrics

Neurosciences

Oncology

General Surgery

Orthopedics, Spine & Rheumatology

Gynecology

Others

Pulmonology 5%

Gynecology 6%

Internal Medicine 8%

Ortho, Spine & Rheumatology 10%

Others 5%

Oncology 17%

Noida Ext.

Q1 FY26

Nephrology & Urology

13%

Neurosciences 10%

Cardiology 10%

Gastroenterology 10%

Operational Highlights for the quarter

Capacity Expansion •

New Delhi facility inaugurated in Jul-25, and Faridabad facility set to be operational in Aug-25, adding ~700 beds to the Group – accelerating growth momentum from Q2 onwards

• Greater Faridabad turns Net Profit positive in Q1 FY26, within one year of its operationalization, demonstrating operational excellence and turnaround capabilities of the Group

Enhancing super specialities, to drive ARPOB • Oncology contributed 10% to Group’s revenues &

~17% to Noida Ext. revenue in Q1 FY26

•

Noida Extension and Greater Noida register record ARPOB at Rs. 39.8k (+7% YoY) and Rs. 38.4k (+9% YoY), , while Noida registers ARPOB growth of 9%, reflecting the continuous focus on improving case mix and payer mix

• Greater Faridabad registers ARPOB of Rs. 31.4k

Improvement in occupancy across our hospitals •

Despite bed additions, occupancy levels improved to 65% in Q1FY26, vs 61% in Q1FY25

•

New Hospitals driving growth, with Jhansi- Orchha occupancy at 59% (vs 45% in Q1 FY25) and Greater Faridabad occupancy at 55% on the currently operational beds (vs 10% in Q1 FY25)

Resolution of Ramraja Hospital land dispute • On June 30, 2025, the Commissionerate of Sagar

Sambhag, Madhya Pradesh has officially set aside their earlier order for take over the premises of Ramraja hospital, thereby confirming the Company's rightful claim to the land

• No further actions or proceedings are pending in

this matter

Inaugurated our New Delhi facility in Q2 FY26 With the 300-bed facility operationalized in July 2025, revenue growth to accelerate from Q2 onwards

Well established Multi-speciality hospital

Established in 2019

Capacity of 300+ Beds

Acquisition Cost ~Rs. 160 crore

Additional Outlay of ~Rs. 60 crore

Located in Model Town, New Delhi

Operationalized on July 14, 2025

❖ Successful acquisition of Model Town Hospital in Delhi through

the e-auction process under the SARFAESI Act, 2002

❖ Hospital well poised to cater a large catchment of residential

and institutional client base in the region

❖ Model Town facility strengthens Yatharth Hospitals’ presence in

the attractive market of Delhi

Inaugurated by Smt. Rekha Gupta, Honourable CM of Delhi

Update on Faridabad acquisition Faridabad facility set to be operational in August 2025, adding 400 beds to the capacity

Yet to commence Multi-speciality hospital

Built on approx. 2 Acre land

Proposed Capacity 400 Beds

Majority stake acquired Rs. 91 crore Additional Outlay of ~Rs. 100 crore

Located in Sec-20, Faridabad, Haryana

To operationalize by August 2025

❖ Strategic collaboration agreement for ~60% stake acquisition

in ~400 bed-hospital in Faridabad

❖ Hospital valued at enterprise value of Rs. 152 crore

❖ Acquisition positions Yatharth as a leading healthcare brand in Faridabad, with one of the largest bed capacity in the region

❖ Hospital’s structure is completed - plans to equip latest

advanced medical equipment & provide high-end super speciality services, including full suite of oncology treatments and robotic surgeries

Clinical Highlights

Achievements in Q1

Clinical Excellence at Yatharth

Initiatives towards Attracting Medical Value Travel

Meeting with Children Heart Fund of Ethiopia

Screening Camp at Black Lion Hospital, Ethiopia

Chinor Medical Centre to act as MVT hub

❖ Yatharth Hospital’s cardiac unit collaborated with Ethiopia’s Children Heart Fund and Black Lion Hospital for

facility upgradation, doctor training and workshop, and patient transfer program

❖ Conducted IVF CME and patient screening in Mauritius, leading to increased patient inflow ❖ Yatharth Information Center to be launched soon in Baghdad, Iraq ❖ Continued OPD and CME initiatives in Uzbekistan and Tajikistan ❖ To collaborate and open a representative office at Chinor Medical Centre, Tashkent, to serve as a hub for

medical value travel in CIS countries like Uzbekistan, Tajikistan, Turkmenistan, Kazakhstan

Profit & Loss Summary

Particulars (Rs mn)

Q1FY26

Q1FY25

Change YoY

Q4FY25

Change QoQ

Revenue from Operations

Medical Consumables & Pharmacy

Employee Expenses

Other Expenses

EBITDA

EBITDA Margin %

Depreciation and amortisation

Financial Cost

Other Income

Profit Before Tax (PBT)

Tax

Profit After Tax (PAT)

PAT Margin %

2,578

535

482

916

645

2,118

468

346

767

537

22%

14%

39%

19%

20%

2,318

465

438

844

570

25.0%

25.3%

(32) Bps

24.6%

149

591

166

425

114

430

126

304

30%

(94%)

166%

38%

32%

40%

129

485

387

11%

15%

10%

13%

41 Bps

16%

(83%)

82%

22%

70%

10%

16.5%

14.3%

214 Bps

16.7%

(22) Bps

At a Glance

Leading Super Speciality Hospital in North India

87%

Hospitals*

Center of Excellence

Beds in Metros*

One-stop destination for patient needs providing all levels of healthcare services from primary to tertiary

2019 Noida Extension 450 beds

2013 Noida 250 beds

2010 Greater Noida 400 beds

2024 Model Town, Delhi 300 beds

2024 Faridabad ~400 beds

2024 Gr. Faridabad 200 beds

2022 Jhansi-Orchha 305 beds

2,300+

Bed Capacity*

+40%

Rs. 32,395

ARPOB

+35%

Revenue (4Y CAGR)

EBITDA (4Y CAGR)

65%

Occupancy

+61%

PAT (4Y CAGR)

Shareholding Pattern

Key Investors

20.5%

4.3%

13.5%

Jun ’25

Kotak Mutual Fund

Bandhan Mutual Fund

Jupiter India

Marval Guru

ICICI Prudential Mutual Fund

Citi Group

SBI Life Insurance

Societe Generale

Canara HSBC Life Insurance

Matthews India

61.6%

Universal Sompo Insurance

Grandeur Peak Funds

Upcoming Hospitals

Promoters

DIIs

FIIs

Others

* Including upcoming hospitals in Faridabad; 4Y CAGR represents FY21-FY25 CAGR

Motilal Oswal Mutual Fund

Carnelian Capital

Edelweiss Alternatives

Param Capital (Mukul Mahavir Agarwal)

Guardian Capital

Kedia Securities (Vijay Kedia)

Our Journey Growing presence across regions and services

Established our first hospital in Greater Noida

Expansion of our first hospital, Greater Noida hospital, to 400 beds

Acquisition of 4th hospital - Jhansi Orchha hospital adding 305 beds, pursuant to acquisition of subsidiary, Ramraja

Acquired 5th hospital – 200 beds in Gr. Faridabad; Raised Rs. 6,250mn via QIP; Acquired 6th and 7th hospital in Delhi & Faridabad

2008

2010

2013

2018

2019

2022

2023

2024

2025

Incorporation of company and commencement of operations

Established our second 250 bedded hospital, in Noida

Commencement of our third hospital, Noida Extension hospital, in May 2019, pursuant to the acquisition of subsidiary AKS in 2016

Listing on NSE & BSE

Inauguration of Delhi facility in Jul-25, adding 300 beds capacity

Acquisitions

Our Hospitals Built on foundation of talent, trust, technology, service and infrastructure

Diversified revenue mix across hospitals (Q1FY26)

Faridabad

Jhansi- Orchha 7%

Greater Noida

30%

Noida

20%

Noida

Extension 34%

Hospitals

Greater Noida

Noida

Noida Extension

Jhansi - Orchha

Greater Faridabad

Year of Operation

2010

Beds Capacity

Census Beds

No of ICU Beds

Occupancy Rate

400

330

112

67%

2013

250

215

86%

2019

2022

2024

450

390

125

61%

305

250

200

180*

59%

55%*

ARPOB (₹)

38,377

31,220

39,830

13,586

31,393

ALOS

4.36

5.01

3.59

3.83

3.94

With recently inaugurated hospital in Delhi (300 beds) & upcoming hospital in Faridabad (400 beds), Yatharth to be amongst the leading hospital chains in North India, in terms of bed strength

Notes: *Given gradual ramp up in bed capacity at Greater Faridabad, the utilization has been computed on 150 beds; All figures as per Q1FY26

Our Mature Hospitals

Greater Noida 2010 Incorporated 400 Beds; 112 ICU Beds (expandable to 600 beds)

Noida 2013 Incorporated 250 Beds; 81 ICU Beds

Noida Extension 2019 Incorporated 450 Beds; 125 ICU Beds (expandable to 700 beds)

All figures for Q1FY26 19

67% Occupancy

Rs.38,377 ARPOB

cardiology, cardiovascular and

thoracic surgery, neurology,

Provides a wide spectrum of super speciality services in the field of

neurosurgery, urology, nephrology, oncology, gastroenterology etc.

4.36 days ALOS

86% Occupancy

Rs.31,220 ARPOB

orthopedics, nephrology, urology, neurosciences, gastroenterology,

Provides services across 30 specialities, including cardiac sciences,

etc.

5.01 days ALOS

61% Occupancy

Rs.39,830 ARPOB

3.59 days ALOS

Super specialities contribute c. 70% of overall business; continued efforts to develop this hospital as Centre of Excellence for oncology and robotic surgeries. In Mar’24, radiation oncology line was inaugurated to provide comprehensive suite of oncology treatments

Accredited by Joint Commission International (JCI) – Noida extension hospital received JCI accreditation, 1st in UP & 7th in North India to achieve this accreditation. Amongst few hospitals to get JCI accreditation in first instance.

Our New Hospitals

Jhansi – Orchha 2022 Acquisition 305 Beds; 76 ICU Beds

Greater Faridabad 2024 Acquisition 200 Beds; 61 ICU Beds

59% Occupancy

Rs.13,586 ARPOB

3.83 days ALOS

55% Occupancy*

Rs.31,393 ARPOB

Hospital

Jhansi-Orchha-Gwalior

region, has

infrastructure to operate all the major super specialities

Acquired in FY22

Acquired in 2024, a newly built hospital with latest

facilities on a 1.25-acre land with empanelment with all

major insurance/TPAs in place

Operationalized on May 12, 2024, expanding Yatharth’s

3.94 days ALOS

presence in North India

Notes: *Given gradual ramp up in bed capacity at Greater Faridabad, the utilization has been computed on 150 beds; All figures as per Q1FY26

Core Strategies driving Growth

Optimizing Infrastructure Enhancing occupancy and ARPOB across our hospitals

Capacity Addition Greenfield and brownfield expansion

Leverage Technology Advanced and high-end medical equipment and technology

Clinical Expertise Attracting best talent to drive super specialities

Optimizing Infrastructure

Capacity Expansion

Leverage Technology

Clinical Expertise

Optimizing Existing Infrastructure

Mature hospitals

New hospitals

Total

42%

50%

55%

45%

63%

54%

66%

61%

47%

23%

FY21

FY22

FY23

FY24

FY25

) % ( y c n a p u c c O

) s R ( B O P R A

21,287

23,511

26,886

26,538

29,646

28,571

34,417

30,829

Optimized scheduling

FY21

FY22

Optimizing Infrastructure

17,692

17,429

17,355

FY23

FY24

FY25

Expand Services

Improve customer service

Diversifying specialities

Our 5-fold approach to optimize existing infra

Enhanced care coordination

Capacity Addition - Greenfield and Brownfield Expansion

Capacity addition trend and roadmap ahead

Operational Beds

New bed addition

Planned bed addition

Target bed capacity

~3,000

450*

Operationalize in Q2 FY26

~400

~200-300

200

May-24

300

Jul-25

305

Apr-22

650

450

May-19

Mar-19

Noida Ext.

Jhansi-Orchha Gr. Faridabad

Delhi

Faridabad

Greenfield / M&A

Brownfield

FY28

*Bed capacity to be expanded by 200 and 250 beds at Greater Noida & Noida Extension in 24-30 months respectively.

Capacity Expansion

Advanced and high-end Medical Equipment and Technology

• Hospitals are equipped with machines and devices with sophisticated technology •

Strive to introduce medical technology and state-of-the-art equipment

Complex procedures

Presence in Hospitals

No. of procedures performed till date

Kidney, Liver & Bone Marrow Transplant

Robotic Surgeries – DaVinci, Mako & Cuvis

Radiation Oncology

Noida Ext & Greater Noida

Noida Ext, Gr. Noida & Gr. Faridabad

Noida Extension

210+

700+

1,900+

Catheterization Laboratory Computerized Tomography Scan (CT Scan)

• • • Magnetic Resonance Imaging (MRI) •

Imaging equipment - Mammography, Advanced EEG, Nerve conduction velocity, advanced surgical equipment etc.

Diagnostic Equipment

Certifications

• We have NABH accreditation for all leading hospitals, including the Greater Faridabad facility. We are in advanced stages of getting NABH accreditation for Jhansi hospital • We have NABL certification for our leading

hospitals.

• Well-equipped modular and other operation theatres with three stage air filtration and laminar flow Operating microscopes, image intensifiers, and laparoscopic equipment

•

Operation Theatres

•

Critical care units are equipped with patient monitoring devices, ventilators and dedicated isolation rooms Facilities for haemodialysis, sustained low- efficiency dialysis, endoscopy and bronchoscopy are available 24x7 by the bedside

Critical care Equipment

Leverage Technology

Attracting Best Talent to Drive Super Specialities

Integrating talent from well-established allied workforce

First mover advantage in building out network across Tier II/III cities

Strategic initiatives aimed to ease attrition

❑ Introduced DNB program across

specialities in 3 of the hospitals

❑ DNB program to reduce attrition of

Resident Medical Doctors

❑ Total 64 resident doctors have joined the

DNB program till date

❑ Keep

staff

global developments concerning the health sector

abreast with

Stronger local connect with people

Promoters being doctors, have better connect with doctors

❑ Provide better doctor visibility amongst the potential patients through marketing and awareness campaigns

Clinical Expertise

Proven Record of Consistent Financial Performance (1/2)

Revenue (Rs mn)

EBITDA (Rs mn) & EBITDA%

9,0 00

8,0 00

7,0 00

6,0 00

5,0 00

4,0 00

3,0 00

2,0 00

1,0 00

2200

210 0

2000

1900

1800

1700

1600

1500

1400

1300

120 0

110 0

1000

90 0

80 0

700

60 0

50 0

40 0

300

200

100

2 6

FY21-25 CAGR @ 40%

5,203

4,009

2,287

8,805

6,705

FY21

FY22

FY23

FY24

FY25

3000 2994 2988 2982 2976 29642970 2958 29462952 2940 2934 2928 2904291029162922 2898 28862892 2880 28682874 28562862 2850 2844 2838 2832 2826 2820 28082814 2802 279 6 279 0 278 4 2778 276 62772 276 0 275 4 274 8 270 627122718272427302736274 2

2694270 0 2688 2682 2676 26642670 2658 26462652 2640 2634 2628 2604261026162622 2598 25862592 2580 25682574 25562562 2550 2544 2538 2532 2526 2520 25082514 24962502 2490 2484 2478 24662472 2460 2454 2448 24362442 2430 2424 240624122418 2400 2394 2388 2364237023762382 2358 23462352 2340 2334 2328 2304231023162322 2298 22862292 226822742280 22562262 2250 2244 2238 22082214222022262232

2094210 0210 621122118212421302136214 2214 8215 4216 0216 621722178218 4219 0219 62202

2088 2082 2076 20642070 2058 20462052 2040 2034 2028 2004201020162022 1998 19861992 1980 19681974 19561962 1950 1944 1938 19261932 1920 19081914 18961902 1890 1884 1878 18661872 1860 1854 1848 1842 1836 1830 1824 180618121818 1800 17881794 1758176 4177017761782 17281734174017461752 16981704171017161722 16861692 1680 16681674 16561662 1650 1644 1638 16261632 1620 16081614 15961602 1590 1584 1578 15661572 1560 1554 1548 1542 1536 1530 1524 150615121518 1500 1494 1488 1464147014761482 1458 14461452 1440 1434 1428 1404141014161422 1398 13861392 136813741380 13561362 1350 1344 1338 13081314132013261332 129 61302 129 0 128 4 1278 126 61272 126 0 125 4 124 8

120 612121218122412301236124 2

120 0

1098110 411101116112211281134114 0114 6115 2115 8116 411701176118 2118 8119 4

10861092 1080 10681074 10561062 1050 1044 1038 10261032 1020 10081014 1002

0612182430364248546066727884909610210811412012613213814415015616216817418018619219820421021622222823424024625225826427027628228829430030631231832433033634234835436036637237838439039640 240 841442042643243844 445 045 646 246 847448 048 649 249 850 451051652252853454 054 655 255 856 457057658 258 859 460 060 661261862463063664 264 865 466 066 667267868 469 069 670270871472072673273874475075676276877478078679279880 481081682282883484 084 685 285 886 487087688 288 889 490 090 691291892493093694 294 895 496 096 697297898 499 099 6

29.3%

27.6%

25.7%

26.8%

25.0%

1,108

1,338

1,799

2,202

FY22

FY23

FY24

FY25

670

FY21

-98%-96%-94%-92%-89%-87%-85%-83%-81%-79%-77%-75%-73%-71%-69%-67%-65%-63%-61%-59%-57%-54%-52%-50%-48%-46%-44%-42%-40%-38%-36%-34%-32%-30%-28 %-26 %-24 %-22%-19 %-17%-15 %-13%-11%-9%-7%-5%-3%-1%1%3%5%7%9%11%14%16%18%20%22%24%26%28%30%

-10 0% -10 2% -10 4% -10 6%

-118%-116%-114%-112%-110%-10 8% -120% -122% -125% -127% -131%-129% -133% -135% -137% -14 1%-139% -14 3% -14 5% -14 7% -15 1%-14 9% -15 3% -15 5% -15 7% -16 0% -16 2% -16 4% -16 6% -16 8% -170% -172% -174% -176% -178% -18 0% -18 2% -18 4% -18 6% -18 8% -19 0% -19 2% -19 5% -19 7% -19 9% -20 1% -20 3% -20 5% -20 7% -211%-20 9% -213% -215% -217% -219% -221% -223% -225% -228% -230 % -232% -234 % -236 % -238 % -24 0% -24 2% -24 4% -24 6% -24 8% -25 0% -25 2% -25 4% -25 6% -25 8% -26 0% -26 3% -26 5% -26 7% -26 9% -271% -273% -275% -277% -279% -28 1% -28 3% -28 5% -28 7% -28 9% -29 1% -29 3% -29 5% -29 8% -300% -302% -304% -306% -308% -310% -312% -314% -316% -318% -320 % -322% -324 % -326 % -328 % -331% -333% -335 % -337% -339 % -341% -343% -345% -347% -349% -351% -353% -355% -357% -359% -361% -363% -366% -368% -370% -372% -374% -376% -378% -380% -382% -384% -386% -388% -390% -392% -394% -396% -398% -401% -403% -405% -407% -411%-409% -413% -415% -417% -419% -421% -423% -425% -427% -429% -431% -434% -436% -438% -440% -442% -444% -446% -448% -450% -452% -454% -456% -458% -460% -462% -464% -466% -469% -471% -473% -475 % -477% -479 % -481% -483% -485% -487% -489% -491% -493% -495% -497% -499% -501% -504% -506% -508% -510% -512% -514% -516% -518% -520% -522% -524% -526% -528% -530% -532% -534% -537% -539% -541% -543% -545% -547% -549% -551% -553% -555% -557% -559% -561% -563% -565% -567% -569% -572% -574 % -576 % -578 % -580% -582% -584% -586% -588% -590% -592% -594% -596% -598% -600% -602% -604% -607% -611%-609% -613% -615% -617% -619% -621% -623% -625% -627% -629% -631% -633% -635% -637% -640% -642% -644% -646% -648% -650% -652% -654% -656% -658% -660% -662% -664% -666% -668% -670 % -672% -675 % -677% -679 % -681% -683% -685% -687% -689% -691% -693% -695% -697% -699% -701% -703% -705 % -707% -710% -712% -714% -716% -718% -720% -722% -724% -726% -728% -730% -732% -734% -736% -738% -740 % -743% -745 % -747% -749 % -751% -753% -755 % -757% -759 % -761% -763% -765 % -767% -771%-769 % -773% -775% -778% -780 % -782% -784 % -786 % -788 % -790 % -792% -794 % -796 % -798 % -800% -802% -804% -806% -808% -810% -813% -815% -817% -819% -821% -823% -825% -827% -829% -831% -833% -835% -837% -839% -841% -843% -846% -848% -850% -852% -854% -856% -858% -860% -862% -864% -866% -868% -870 % -872% -874 % -876 % -878 % -881% -883% -885% -887% -889% -891% -893% -895% -897% -899% -901% -903% -905% -907% -911%-909% -913% -916% -918% -920% -922% -924% -926% -928% -930% -932% -934% -936% -938% -940% -942% -944% -946% -949% -951% -953% -955% -957% -959% -961% -963% -965% -967% -969% -971% -973% -975 % -977% -979 % -981% -984% -986% -988% -990% -992% -994% -996% -998% -10 00%

PAT (Rs mn) & PAT%

Operating Cash Flows (Rs mn)

8.6%

11.0%

12.6%

17.1%

14.8%

196

FY21

442

FY22

658

FY23

1,145

1,306

FY24

FY25

-98%-96%-94%-92%-90%-88%-86%-84%-82%-80%-78%-76%-74%-72%-70%-68%-66%-64%-62%-60%-58%-55%-53%-51%-49%-47%-45%-43%-41%-39%-37%-35%-33%-31%-29 %-27%-25 %-23%-21%-19 %-17%-15 %-13%-11%-9%-7%-4%-2%0%2%4%6%8%10%12%14%16%18%20%

-10 0% -10 2% -10 4% -10 6%

-121%-119%-117%-115%-113%-111%-10 9% -123% -125% -127% -131%-129% -133% -135% -137% -14 1%-139% -14 3% -14 5% -14 7% -15 1%-14 9% -15 3% -15 5% -15 7% -16 0% -16 2% -16 4% -16 6% -16 8% -170% -172% -174% -176% -178% -18 0% -18 2% -18 4% -18 6% -18 8% -19 0% -19 2% -19 4% -19 6% -19 8% -20 0% -20 2% -20 4% -20 6% -211%-20 8% -213% -215% -217% -219% -221% -223% -225% -227% -229% -231% -233% -235 % -237% -239 % -24 1% -24 3% -24 5% -24 7% -24 9% -25 1% -25 3% -25 5% -25 7% -25 9% -26 2% -26 4% -26 6% -26 8% -270% -272% -274% -276% -278% -28 0% -28 2% -28 4% -28 6% -28 8% -29 0% -29 2% -29 4% -29 6% -29 8% -300% -302% -304% -306% -308% -310% -313% -315% -317% -319% -321% -323% -325 % -327% -329 % -331% -333% -335 % -337% -339 % -341% -343% -345% -347% -349% -351% -353% -355% -357% -359% -361% -364% -366% -368% -370% -372% -374% -376% -378% -380% -382% -384% -386% -388% -390% -392% -394% -396% -398% -400% -402% -404% -406% -408% -410% -412% -415% -417% -419% -421% -423% -425% -427% -429% -431% -433% -435% -437% -439% -441% -443% -445% -447% -449% -451% -453% -455% -457% -459% -461% -463% -466% -468% -470 % -472% -474 % -476 % -478 % -480% -482% -484% -486% -488% -490% -492% -494% -496% -498% -500% -502% -504% -506% -508% -510% -512% -514% -517% -519% -521% -523% -525% -527% -529% -531% -533% -535% -537% -539% -541% -543% -545% -547% -549% -551% -553% -555% -557% -559% -561% -563% -565% -568% -570 % -572% -574 % -576 % -578 % -580% -582% -584% -586% -588% -590% -592% -594% -596% -598% -600% -602% -604% -606% -608% -610% -612% -614% -616% -619% -621% -623% -625% -627% -629% -631% -633% -635% -637% -639% -641% -643% -645% -647% -649% -651% -653% -655% -657% -659% -661% -663% -665% -667% -670 % -672% -674 % -676 % -678 % -680% -682% -684% -686% -688% -690% -692% -694% -696% -698% -700 % -702% -704 % -706 % -708 % -710% -712% -714% -716% -718% -721% -723% -725% -727% -729% -731% -733% -735% -737% -739% -741% -743% -745 % -747% -749 % -751% -753% -755 % -757% -759 % -761% -763% -765 % -767% -769 % -772% -774% -776% -778% -780 % -782% -784 % -786 % -788 % -790 % -792% -794 % -796 % -798 % -800% -802% -804% -806% -808% -810% -812% -814% -816% -818% -820% -823% -825% -827% -829% -831% -833% -835% -837% -839% -841% -843% -845% -847% -849% -851% -853% -855% -857% -859% -861% -863% -865% -867% -869% -871% -874 % -876 % -878 % -880% -882% -884% -886% -888% -890% -892% -894% -896% -898% -900% -902% -904% -906% -908% -910% -912% -914% -916% -918% -920% -922% -925% -927% -929% -931% -933% -935% -937% -939% -941% -943% -945% -947% -949% -951% -953% -955% -957% -959% -961% -963% -965% -967% -969% -971% -973% -976 % -978 % -980% -982% -984% -986% -988% -990% -992% -994% -996% -998% -10 00%

1800 1780178517901795 176 517701775

1695170017051710171517201725173017351740174517501755176 0

1690 1685 1680 1675 16651670 1660 1655 1650 1645 1640 1635 1630 1625 1620 160516101615 1600 1595 1590 1585 1580 156515701575 1560 1555 1550 1545 1540 1535 1530 1525 1520 150515101515 1500 1495 1490 1485 1480 146514701475 1460 1455 1450 1445 1440 1435 1430 1425 1420 140514101415 1400 1395 1390 1385 1365137013751380 1360 1355 1350 1345 1340 1335 130513101315132013251330 1300 129 5 129 0 128 5 128 0 126 512701275 126 0 125 5 125 0 124 5 120 5121012151220122512301235124 0

120 0

1095110 0110 5111011151120112511301135114 0114 5115 0115 5116 0116 511701175118 0118 5119 0119 5

1090 1085 1080 106510701075 1060 1055 1050 1045 1040 1035 1030 1025 1020 100510101015 1000

-10 0-95-90-85-80-75-70-65-60-55-50-45-40-35-30-25-20-15-10-50510152025303540455055606570758085909510010511011512012513013514014515015516016517017518018519019520020521021522022523023524024525025526026527027528028529029530030531031532032533033534034535035536036537037538038539039540 040 541041542042543043544 044 545 045 546 046 547047548 048 549 049 550 050 551051552052553053554 054 555 055 556 056 557057558 058 559 059 560 060 561061562062563063564 064 565 065 566 066 567067568 068 569 069 570070571071572072573073574074575075576076577077578078579079580 080 581081582082583083584 084 585 085 586 086 587087588 088 589 089 590 090 591091592092593093594 094 595 095 596 096 597097598 098 599 099 5

65%

54%

437

FY21

599

FY22

48%

638

FY23

-2%

-31

FY24

Cash Conversion

68%

1,496

FY25

70% 69 % 68 % 67% 66 % 65 % 64 % 63% 62% 61% 60 % 59 % 58 % 57% 56 % 55 % 54 % 53% 52% 51% 50 % 49 % 48 % 47% 46 % 45 % 44 % 43% 42% 41% 40 % 39% 38% 37% 36% 35% 34% 33% 32% 31% 30% 29% 28% 27% 26% 25% 24% 23% 22% 21% 20% 19% 18% 17% 16% 15% 14% 13% 12% 11% 10% 9% 8% 7% 6% 5% 4% 3% 2% 1% 0% -1% -2% -3% -4% -5% -6% -7% -8% -9% -10 % -11% -12% -13% -14 % -15 % -16 % -17% -18 % -19 % -20 % -21% -22% -23% -24 % -25 % -26 % -27% -28 % -29 % -30% -31% -32% -33% -34% -35% -36% -37% -38% -39% -40% -41% -42% -43% -44% -45% -46% -47% -48% -49% -50% -51% -52% -53% -54% -55% -56% -57% -58% -59% -60% -61% -62% -63% -64% -65% -66% -67% -68% -69% -70% -71% -72% -73% -74% -75% -76% -77% -78% -79% -80% -81% -82% -83% -84% -85% -86% -87% -88% -89% -90% -91% -92% -93% -94% -95% -96% -97% -98% -99% -10 0%

Proven Record of Consistent Financial Performance (2/2)

RoCE (%)

Net Worth (Rs mn)

27%

28%

29%

ROCE temporarily dipped due to fund raise - reflects ongoing integration of acquisitions & medical infrastructure

18%

FY21

FY22

FY23

FY24

Gross Block (Rs mn)

Capex per bed

3.91

3.72

3.07

9 1 3 4

0 9 0 4

3.90

0 6 2 , 6

19%

FY25

4.81

2 8 0 , 1 1

5.0 0

4.8 0

4.6 0

4.4 0

4.2 0

4.0 0

3.8 0

3.6 0

3.4 0

3.2 0

3.0 0

2.8 0

2.6 0

2.4 0

2.2 0

2.0 0

1.8 0

1.6 0

1.4 0

1.2 0

1.0 0

0.8 0

0.6 0

0.4 0

0.2 0

0.0 0

16,371

8,743

807

FY21

1,169

1,830

FY22

FY23

FY24

FY25

Net Debt (Rs mn)

Net Debt/EBITDA

2.8

1,883

2.3

2,517

1.7

2,290

Robust Cash Position

-1,540

-5,032

-0.9

2000 0

15000

10000

50 00

10000

95 00

90 00

85 00

80 00

7500

7000

65 00

60 00

55 00

50 00

45 00

40 00

3500

3000

2500

2000

1500

1000

50 0

-500

-10 00

-15 00

-20 00

-25 00

-3000

-3500

-4000

-4500

-5000

-5500

-6000

-6500

FY22

FY23

FY24

FY25

FY21

FY22

FY23

FY24

-2.3

FY25

100 00

800 0

600 0

400 0

200 0

4 7 3 3

FY21

0.27

0.26

0.25

0.24

0.23

0.22

0.21

0.2

0.19

0.18

0.17

0.16

0.15

0.14

0.13

0.12

0.11

0.1

0.09

0.08

0.07

0.06

0.05

0.04

0.03

0.02

0.01

4.20

4.10

4.00

3.90

3.80

3.70

3.60

3.50

3.40

3.30

3.20

3.10

3.00

2.90

2.80

2.70

2.60

2.50

2.40

2.30

2.20

2.10

2.00

1.9 0

1.8 0

1.70

1.6 0

1.5 0

1.4 0

1.30

1.20

1.10

1.0 0

0.90

0.80

0.70

0.60

0.50

0.40

0.30

0.20

0.10

0.00

-0.10

-0.20

-0.30

-0.40

-0.50

-0.60

-0.70

-0.80

-0.90

-1.00

-1.10

-1.20

-1.30

-1.40

-1.50

-1.60

-1.70

-1.80

-1.90

-2.00

-2.10

-2.20

-2.30

-2.40

-2.50

-2.60

-2.70

-2.80

-2.90

-3.0 0

Consistent Performance across Operational Parameters

0.9

0.8

0.7

0.6

0.5

0.4

0.3

0.2

0.1

Occupancy (%)

42%

50%

45%

54%

61%

FY21

FY22

FY23

FY24

FY25

1000

50 0

-500

-10 00

90 00

80 00

7000

60 00

50 00

40 00

3000

2000

1000

2,287

227

2,060

FY21

IPD/OPD Revenue (in ‘000s)

IPD Revenue

OPD Revenue

4,009

546

3,464

5,203

684

4,519

6,705

819

5,886

8,805

1,009

7,797

89 00 88 00 8700 86 00 85 00 84 00 8300 8200 8100 80 00 7900 7800 7700 7600 7500 7400 730 0 720 0 7100 7000 69 00 68 00 6700 66 00 65 00 64 00 6300 6200 6100 60 00 59 00 58 00 5700 56 00 55 00 54 00 5300 5200 5100 50 00 49 00 48 00 4700 46 00 45 00 44 00 4300 4200 4100 40 00 3900 3800 370 0 3600 3500 3400 3300 3200 3100 3000 2900 2800 270 0 2600 2500 2400 2300 2200 210 0 2000 1900 1800 1700 1600 1500 1400 1300 120 0 110 0 1000 90 0 80 0 700 60 0 50 0 40 0 300 200 100 0 -10 0 -20 0 -300 -400 -500 -600 -700 -800 -900 -10 00 -1100 -1200 -1300 -14 00 -15 00 -16 00 -1700 -18 00 -19 00 -20 00 -2100 -2200 -230 0 -24 00 -25 00 -26 00 -2700 -28 00 -29 00 -3000

FY22

FY23

FY24

FY25

FY22

FY23

FY24

FY25

ARPOB (Rs.)

ALOS (days)

21,287

23,511

26,538

28,571

30,829

FY21

FY22

FY23

FY24

FY25

FY21

FY22

5.03

5.20

4.32

FY23

4.78

FY24

4.33

FY25

Experienced Board and Leadership Team

Dr. Ajay Kumar Tyagi Chairman & Whole-time Director

17+ yrs of experience Bachelor of medicine, surgery, and diploma in orthopaedics

Dr. Kapil Kumar Managing Director

17+ yrs of experience Bachelor of medicine, surgery, and master of orthopedic surgery, Magister chirurgiae in orthopaedics

Promila Bhardwaj Independent Director

35+ yrs of experience Bachelor of arts, Master’s of arts in English, philosophy in social sciences and diploma in public administration

Mukesh Sharma Independent Director

35+ yrs of experience Bachelor’s in science agriculture & animal husbandry Master’s in business administration Post graduate diploma in labour law & welfare, & personnel mgmt. Bachelor’s of law

Yatharth Tyagi Whole-time Director

Bachelor’s in business mgmt. from Leeds Beckett University Master’s of science in International Health Management from Imperial College, London

Sanjeev Upadhyaya Independent Director

20+ yrs of experience Bachelor’s in medicine, surgery Doctor of medicine in community medicine

Amit Kumar Singh Chief Executive Officer

Nitin Gupta COO & President - Finance

Pankaj Prabhakar Chief Financial Officer

Ashutosh Kumar Jha Group Chief, Strategy, M&A and IR

Sonu Goyal Group Finance Controller

Ritesh Mishra CS & Compliance Officer

20+ yrs of exp

21+ yrs of experience

20+ yrs of exp

18+ yrs of experience

16+ yrs of experience

10+ yrs of experience

s r o t c e r i D

f o d r a o B

s P M S / s P M K

Thank You

Yatharth Hospital & Trauma Care Services Ltd

Investor Relations Contact

Mr. Ashutosh Kumar Jha, Group Chief – Strategy, M&A and IR

investor.relations@yatharthhospitals.com

CIN: L85110DL2008PLC174706

www.yatharthhospitals.com

← All Transcripts YATHARTH Stock Page →

Yatharth Hospital & Trauma Care Services Limited has informed the Exchange about Investor Presentation

Market Movers